{"id":"W3201611853","doi":"10.1136/jitc-2021-003122","title":"Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates","year":2021,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Ovarian Cancer Academy; Merck Sharp and Dohme; U.S. Department of Defense","keywords":"Carboplatin; Medicine; Ovarian cancer; Pembrolizumab; Fallopian tube cancer; Oncology; Fallopian tube; Internal medicine; Gynecology; Cancer; Chemotherapy; Immunotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000227919,0.0003086895,0.0008463828,0.000089733,0.0002588237,0.00008273354,0.00007115864,0.0001149848,0.0001354705],"category_scores_gemma":[0.00001969669,0.0002327176,0.0001821287,0.0001298944,0.0001282024,0.000120437,0.00002215714,0.0002460689,9.398953e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003640825,"about_ca_system_score_gemma":0.001028178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003476645,"about_ca_topic_score_gemma":0.000541258,"domain_scores_codex":[0.9983259,0.00004113384,0.0006033977,0.0003517916,0.0003191096,0.0003586771],"domain_scores_gemma":[0.9985617,0.0002036114,0.0003962326,0.0002220792,0.0004601433,0.000156237],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1119882,0.00167553,0.111244,0.003093885,0.00993054,0.0002003139,0.00397841,0.0002107326,0.1392294,0.001978509,0.001317352,0.6151531],"study_design_scores_gemma":[0.09094942,0.01054254,0.8099701,0.005650613,0.001825613,0.000750581,0.0008771074,0.0006647842,0.03109629,0.0005936215,0.04614267,0.0009366641],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8404892,0.1533594,0.00014913,0.00331056,0.001085934,0.00105442,0.0003539964,0.00001535219,0.0001820403],"genre_scores_gemma":[0.9247003,0.06763851,0.004447265,0.000375466,0.0006745614,0.0006940726,0.00007208242,0.0001345705,0.001263243],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6987261,"threshold_uncertainty_score":0.948995,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01718030431608468,"score_gpt":0.3050659985256309,"score_spread":0.2878856942095462,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}